ACB $3.760 (7.12%)

ACNNF $0.185 (-3.14%)

AERO $0.800 (0%)

AGEEF $0.210 (-3.23%)

ALEAF $0.607 (3.84%)

AMMJ $0.228 (0%)

APHA $5.430 (24.54%)

ARNA $48.900 (3.34%)

ATT:CNX $0.080 (0%)

ATTBF $0.017 (-7.95%)

AUSA:CNX $0.640 (3.23%)

AUSAF $0.480 (-4%)

AVXL $2.750 (3.77%)

BAMM:CNX $1.260 (-1.56%)

BBM:CNX $0.140 (-9.68%)

BBRRF $0.115 (3.42%)

BE:CNX $0.025 (0%)

BIO:CNX $0.245 (8.89%)

BLEVF $0.025 (23.65%)

BLO:CNX $0.600 (20%)

BLOZF $0.457 (17.15%)

BUDZ $0.400 (0%)

BXNG $0.354 (-1.94%)

CADMF $0.440 (-14.15%)

CALI:CNX $0.105 (5%)

CANN $0.630 (-1.56%)

CARA $19.380 (2.76%)

CBII:CNX $0.100 (-4.76%)

CBIIF $0.086 (-13.39%)

CBWTF $0.569 (0.92%)

CGC $20.100 (6.57%)

CGRW $0.210 (-4.5%)

CHOO:CNX $0.245 (-3.92%)

CHOOF $0.188 (-3.59%)

CNAB $0.340 (6.92%)

CNBX $0.218 (3.42%)

CNGGF $0.980 (0%)

CODI $19.650 (1.24%)

CPMD $2.140 (0%)

CRBP $4.840 (4.09%)

CRON $8.320 (5.79%)

CROP:CNX $0.035 (16.67%)

CRTPF $2.087 (-2.49%)

CRXPF $0.027 (-11.67%)

CSI:CNX $0.580 (-12.12%)

CTST $1.380 (32.69%)

CURR $3.700 (-0.8%)

CVSI $1.940 (4.3%)

DIGP $0.095 (9.2%)

DXBRF $0.357 (2%)

EAPH $0.003 (0%)

EAT:CNX $0.115 (21.05%)

EEVVF $0.160 (6.67%)

EMHTF $0.625 (-15.57%)

EPWCF $0.039 (-22.16%)

EVIO $0.400 (-12.07%)

FFRMF $0.045 (7.14%)

FFT:CNX $0.055 (10%)

FNNZF $0.077 (-2.84%)

FSDDF $0.041 (-2.15%)

GGTTF $0.165 (-4.27%)

GLDFF $0.024 (3.91%)

GLH:CNX $0.030 (0%)

GLNNF $0.059 (-18.33%)

GNBT $2.007 (-1.62%)

GRIN:CNX $0.170 (-2.86%)

GRWG $3.940 (11.93%)

GSTR:CNX $0.110 (-8.33%)

GTBIF $9.190 (4.75%)

GTII:CNX $12.110 (2.89%)

GWPH $120.330 (3.55%)

HEXO $2.560 (8.47%)

HHPHF $0.058 (-14.56%)

HLSPY $0.510 (0%)

HMLSF $8.265 (5.29%)

HMPPF $0.498 (0%)

HRVOF $0.300 (27.61%)

HSTRF $0.244 (0%)

HUGE:CNX $9.045 (-10%)

IAN:CNX $1.800 (14.65%)

IGC $0.917 (6.99%)

IGXT $0.660 (1.54%)

IIPR $78.210 (0.51%)

IMLFF $0.223 (10.3%)

INQD $0.004 (-2.78%)

IONC:CNX $0.040 (0%)

IONKF $0.032 (4.31%)

ISOL:CNX $0.280 (12%)

ISOLF $0.210 (0.24%)

ITHUF $1.380 (11.29%)

IVITF $0.122 (-5.85%)

JWCAF $0.349 (10.53%)

KALTF $0.027 (0.37%)

KBEV:CNX $0.210 (23.53%)

KBEVF $0.156 (16.48%)

KHRNF $0.847 (8.63%)

KSHB $1.380 (0%)

LHS:CNX $0.400 (2.56%)

LHSIF $0.295 (-0.51%)

LOVE:CNX $0.170 (3.03%)

LXLLF $0.344 (0%)

LXRP $0.515 (0.98%)

LXX:CNX $0.680 (19.3%)

MCIG $0.034 (7.98%)

MDCL $3.490 (-0.29%)

MEDIF $3.197 (7.29%)

MGWFF $0.063 (11.71%)

MICWF $0.139 (6.85%)

MJ:CNX $0.170 (-15%)

MJNA $0.026 (0%)

MNTR $0.150 (0%)

MRRCF $0.064 (-9.2%)

MWM:CNX $0.180 (2.86%)

MYM:CNX $0.125 (4.17%)

MYMMF $0.094 (4.44%)

NCNNF $0.399 (5.04%)

NDVAF $0.187 (7.92%)

NGW:CNX $0.195 (0%)

NRXCF $0.043 (0%)

NSPDF $0.060 (-25.47%)

NTEC $0.739 (2.58%)

NVTQF $0.115 (0%)

NWKRF $0.424 (0%)

NXGWF $0.151 (-0.05%)

NXTTF $0.330 (4.1%)

OH:CNX $6.380 (10.76%)

ORHOF $4.856 (13.12%)

OWCP $0.008 (-11.7%)

PHGI:CNX $0.475 (-3.06%)

PHGRF $0.362 (13.09%)

PHVAF $0.161 (8.12%)

PILL:CNX $0.610 (38.64%)

PKG:CNX $0.090 (-5.26%)

PLPRF $2.298 (3.03%)

PLUS:CNX $2.990 (1.36%)

PMCB $0.033 (-6.98%)

PNPL $0.300 (0%)

POTN $0.028 (12.7%)

PRCNF $0.090 (5.57%)

PTNYF $0.075 (-12.06%)

QCA:CNX $0.135 (12.5%)

RDDTF $0.413 (10.29%)

RLLVF $0.032 (-18.88%)

RMHB $0.039 (-4.88%)

RQB:CNX $0.230 (0%)

RQHTF $0.411 (9.63%)

RVVQF $0.173 (-9.42%)

SLNG:CNX $0.440 (2.33%)

SMG $101.210 (-0.6%)

SNN:CNX $1.390 (6.11%)

SNNVF $1.019 (0.39%)

SOL:CNX $0.880 (-5.38%)

SOLCF $0.686 (-3.36%)

SPLIF $0.089 (23.61%)

SPRWF $0.729 (5.58%)

SRNA $0.070 (-9.56%)

STEM:CNX $1.480 (8.03%)

STMH $1.120 (10.89%)

SUN:CNX $0.300 (-9.09%)

TBPMF $0.205 (2.48%)

TCAN:CNX $0.620 (12.73%)

TCNAF $0.447 (0%)

TER:CNX $5.020 (14.09%)

TGEN $2.480 (-4.25%)

TGIF:CNX $0.265 (17.78%)

TGIFF $0.195 (19.63%)

THC:CNX $0.140 (12%)

THCBF $0.111 (8.25%)

TLRY $22.120 (7.07%)

TOKI:CNX $0.045 (0%)

TRLFF $0.136 (-7.59%)

TRPX $2.530 (10.96%)

TRSSF $3.832 (16.48%)

TRTC $0.287 (-2.05%)

TURV $0.230 (-8%)

VAPN:CNX $0.620 (-11.43%)

VBIO $0.120 (-20%)

VIDA:CNX $0.195 (-7.14%)

VIN:CNX $0.085 (13.33%)

VPRB $0.040 (0%)

VRNDF $0.465 (-0.91%)

VRT:CNX $0.240 (6.67%)

VRTHF $0.179 (-7.93%)

VVCIF $0.220 (9.4%)

WAYL:CNX $0.740 (0%)

WDDMF $0.944 (3.76%)

WLDFF $0.221 (-11.68%)

XXII $2.030 (2.01%)

ZDPY $0.295 (0%)

ZYNE $7.920 (3.8%)

Back

Aleafia Health Announces Termination of Supply Agreement With Aphria Inc.

Oct 8, 2019 • 12:03 PM GMT+0000
3 MIN READ  •  By mberger
Share Share - Facebook Share - Twitter

Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) announces that it has provided Aphria Inc. (TSX: APHA, NYSE: APHA) (“Aphria”) with a formal notice of the termination, effective October 7, 2019, of the wholesale cannabis supply agreement (the “Supply Agreement”) dated September 11, 2018 between Aphria and Emblem Corp. (“Emblem”), a wholly-owned subsidiary of the Company, providing for the provision by Aphria of up to 175,000 kg equivalents of cannabis products over an initial five-year term, commencing May 1, 2019.

Following Aphria’s failure to meet its supply obligations under the Supply Agreement, Emblem has exercised its contractual right to terminate the Supply Agreement in accordance with its terms. The termination of the Supply Agreement by Emblem was made without prejudice to its rights accrued to the date of termination (including its rights to be refunded the unused balance of its deposit) and its rights to seek damages as a result of Aphria’s default and termination thereunder.

The Company does not believe the termination of the Supply Agreement will materially and adversely affect the Company’s business, operations or results.

For Investor and Media Relations, please contact:

Nicholas Bergamini, VP Investor Relations
1-833-TSX-ALEF (879-2533)
IR@AleafiaHealth.com
LEARN MORE: www.AleafiaHealth.com

About Aleafia Health:

Aleafia Health is a leading, vertically integrated cannabis health and wellness company with four primary business units: Cannabis Cultivation & Products, Health & Wellness Clinics, Cannabis Education, and Consumer Experience with ecommerce, retail distribution and provincial supply agreements.

Aleafia Health owns three major cannabis product & cultivation facilities, two of which are licensed and operational including the first large-scale, operational outdoor cultivation facility in Canadian history. The Company produces a diverse portfolio of commercially proven, high-margin derivative products including oils, capsules and sprays. Aleafia Health operates the largest national network of medical cannabis clinics and education centres staffed by MDs, nurse practitioners and educators and has international operations in three continents.

Innovation is at the heart of Aleafia Health competitive advantage. The Company maintains a medical cannabis dataset with over 10 million data points to inform proprietary illness-specific product development and its highly differentiated education platform FoliEdge Academy. The Company is committed to creating sustainable shareholder value and has been named the 2019 top performing company of the year by the TSX Venture Exchange prior to graduation to the TSX.

Forward Looking Information

This news release contains forward-looking information within the meaning of applicable Canadian and United States securities laws. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes” or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company or its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including risks contained in the Company’s annual information form filed with Canadian securities regulators available on the Company’s SEDAR profile at www.sedar.com. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company does not undertake any obligation to publicly update such forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

Primary Logo
Share Share - Facebook Share - Twitter

Tags

Authored By

mberger

Michael Berger is the Founder of Technical420 and Managing Partner of StoneBridge Partners. Prior to entering the cannabis industry, Michael worked as an Equity Research Analyst at Raymond James Financial and recognized a major information void when it comes to the cannabis industry while working in this position. Michael continues to be one of the top authorities on cannabis equities in the industry.

Comments

Get the Latest Cannabis News & Stock Picks.

Enter your email below to join the official Technical420 newsletter.

 All good -- no spamming here.